NOVN.SW
Price:
$126.28
Market Cap:
$297.64B
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1996-03-08
Stock Exchange
SIX
Ticker
NOVN.SW
Dividends are a key part of long-term returns for investors, and Novartis AG (NOVN.SW) has a track record worth reviewing. Looking at dividend history for NOVN.SW gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2026-03-10
Dividend Yield
2.93%
Annual Dividend
$3.70
P/E Ratio
18.38
Payout Ratio
0.61
Dividend per Share
$4.57
EPS
6.87
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2026-03-10 | $3.7 | $3.7 | 2026-03-12 | |
| 2025-03-11 | $3.5 | $3.5 | 2025-03-13 | 2025-03-12 |
| 2024-03-07 | $3.3 | $3.3 | 2024-03-11 | |
| 2023-03-09 | $3.84 | $3.2 | 2023-03-13 | |
| 2022-03-08 | $3.1 | $3.1 | 2022-03-10 | |
| 2021-03-04 | $3 | $3 | 2021-03-08 | |
| 2020-03-03 | $2.95 | $2.95 | 2020-03-05 | 2020-01-29 |
| 2019-03-04 | $2.85 | $2.85 | 2019-03-06 | 2019-01-30 |
| 2018-03-06 | $2.8 | $2.8 | 2018-03-08 | 2018-01-24 |
| 2017-03-02 | $2.75 | $2.75 | 2017-03-06 | 2017-01-25 |
| 2016-02-25 | $2.7 | $2.7 | 2016-02-29 | 2016-01-27 |
The table below shows Novartis AG (NOVN.SW) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Novartis AG (NOVN.SW) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Roche Holding AG (ROG.SW) | 0.03% |
| Abbott Laboratories (ABT.SW) | 0.03% |
| Cosmo Pharmaceuticals N.V. (COPN.SW) | 0.03% |
| Sandoz Group AG (SDZ.SW) | 0.01% |
| Siegfried Holding AG (SFZN.SW) | 0.01% |
| IVF Hartmann Holding AG (VBSN.SW) | 0.03% |
| Galenica AG (GALE.SW) | 0.03% |
| Zimmer Biomet Holdings, Inc. (ZBH.SW) | 0.01% |
| COLTENE Holding AG (CLTN.SW) | 0.04% |
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Novartis AG (NOVN.SW) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is NOVN.SW’s dividend yield?
What is the difference between regular and special dividends?
Has NOVN.SW increased its dividends over time?
Why might dividend history data be delayed?
How often does NOVN.SW pay dividends?
What factors impact NOVN.SW's dividend payments?
Can dividends change over time?
What is NOVN.SW’s next dividend date?